Pain Phenotype and Response to Corticosteroid Injection in Patients With Subacromial Pain Syndrome (SAPS)

Conditions: Subacromial Pain Syndrome, Rotator Cuff Related Shoulder Pain, Shoulder Pain, Shoulder Impingement Syndrome, SAPS

Sex: All

Ages: 18 Years – 70 Years

Healthy volunteers: No

Enrollment: 134

Sponsor: Vejle Hospital

Summary

The goal of this prospective cohort study is to investigate whether pain phenotype is associated with subsequent change in pain intensity after corticosteroid injection given as part of routine care in patients diagnosed with SAPS. The main question it aims to answer is: Does change in shoulder pain from baseline to 4 weeks after corticosteroid injection differ between patients classified as having a nociplastic pain phenotype and those classified as having a non-nociplastic pain phenotype?

Eligibility Criteria

Inclusion Criteria: 1. Diagnosed with SAPS (dm751, dm753, dm754, dm755 2. Shoulder pain ≥ 3 months 3. ≥ 3 out of 5 specific shoulder test 4. Age 18-70 years 5. Increased pain during active arm elevation 6. Pain during active elevation ≥ 3 (VAS) 7. Receving a corticosteroid injection based on routine clinical proctice Exclusion Criteria: 1. Severe visual impairment 2. Epilepsy 3. Severe cognitive or physical impairment 4. Language barrier (Danish) 5. Receving a corticosteroid injection at a site other than the subacromial bursa (e.g. acromioclavicular joint or intra-articular injection)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07792421). StuddyBuddy aggregates publicly available trial information.